The latest announcement is out from NewGenIvf Group ( (NIVF) ).
On April 15, 2025, NewGenIvf Group Limited’s Board of Directors approved a reverse stock split at a ratio of one share for ten shares, effective around May 2, 2025. This move aims to maintain compliance with Nasdaq’s minimum bid price requirement, reducing the number of outstanding Class A Ordinary Shares from 7,508,094 to approximately 750,809. The reverse stock split will also adjust options, warrants, and other convertible securities accordingly.
More about NewGenIvf Group
NewGenIvf Group Limited operates in the healthcare industry, focusing on fertility treatments and reproductive health services. The company is based in Bangkok, Thailand, and is listed on the Nasdaq Capital Market.
YTD Price Performance: -95.05%
Average Trading Volume: 3,129,382
Technical Sentiment Signal: Buy
Current Market Cap: $2.08M
Learn more about NIVF stock on TipRanks’ Stock Analysis page.